| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 4,919,625 | 49,491,000 | 27.14% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 2,144,387 | 39,564,000 | 21.69% | ||
| 3 | SALIX PHARMACEUTICALS INC | 300,000 | 34,482,000 | 18.91% | ||
| 4 | Opko Health, Inc. | 14,000,000 | 20,573,000 | 11.28% | PRN | |
| 5 | BIOMARIN | 182,300 | 16,480,000 | 9.04% | ||
| 6 | MERRIMACK PHARMACEUTI | 5,500,000 | 10,225,000 | 5.61% | PRN | |
| 7 | HORIZON PHARMA PLC | 490,000 | 6,316,000 | 3.46% | ||
| 8 | MIRATI THERAPEUTICS INC COM | 238,432 | 4,416,000 | 2.42% | ||
| 9 | OncoGenex Pharmaceuticals Inc | 365,000 | 836,000 | 0.46% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-15-000607, filed 2015.01.27).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
